Immunostimulatory nucleic acids for the treatment of asthma and allergy
First Claim
Patent Images
1. A method for treating or preventing allergy or asthma, comprising administering to a subject a poly-G nucleic acid in an effective amount for treating or preventing allergy or asthma.
0 Assignments
0 Petitions
Accused Products
Abstract
The invention involves administration of an immunostimulatory nucleic acid alone or in combination with an asthma/allergy medicament for the treatment or prevention of asthma and allergy in subjects. The combination of drugs are administered in synergistic amounts or in various dosages or at various time schedules. The invention also relates to kits and compositions concerning the combination of drugs.
-
Citations
36 Claims
-
1. A method for treating or preventing allergy or asthma, comprising
administering to a subject a poly-G nucleic acid in an effective amount for treating or preventing allergy or asthma.
-
11. A composition comprising a poly-G nucleic acid in an aerosol formulation.
-
12. A method for treating or preventing asthma or allergy in a hypo-responsive subject, comprising:
administering to a hypo-responsive subject having asthma or allergy or at risk of developing asthma or allergy an immunostimulatory nucleic acid in an effective amount for treating or preventing asthma or allergy. - View Dependent Claims (13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)
-
36. A method for preventing asthma or allergy in a subject at risk of developing asthma or allergy, comprising:
administering to a subject at risk of developing asthma or allergy an effective amount of an immunostimulatory nucleic acid substantially prior to an asthmatic or an allergic event.
Specification